Login

Christoph Vilanek, CEO of Freenet AG, speaking at the 10th International Brand Colloquium in 2013. 00:10:00

Share On Facebook Share On Twitter

Christoph Vilanek is Chairman-Mgmt Board/CEO at freenet AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Teaching Gen Z Financial Wisdom | BlueTrust Tips
00:10:00
Introducing GOVERN Function and Enhanced Framework Functions | Domenico Favuzzi, President & CEO of Exprivia SpA
00:10:00
Billionaire Hedge Fund Manager David Tepper to Return Outside Capital and Transition Appaloosa Management to Family Office, Reports Bloomberg
00:10:00
Navitas Semiconductor CEO Gene Sheridan provides insights on Q2 results, business challenges, and future prospects on 'Power Lunch'.|Gene Sheridan, CEO of Navitas Semiconductor
00:10:00
CEO Thomas Schulz on Bilfinger's Q2 Earnings, Europe's Energy Crisis, and Cost Pressures | Thomas Schulz - CEO of Bilfinger
00:10:00
CEO Talks Mastel TV interview with Otto Toto Sugiri | Otto Toto Sugiri, CEO, DCI Indonesia Tbk PTDCII:JKT
00:10:00
Drax Group CEO Will Gardiner responds to inquiries regarding Drax's Canadian biomass operations in a video statement and provides additional details in the accompanying article.
00:10:00
The Hedge Fund Comeback: Insights from Industry Leaders | Steve Cohen, Ilana Weinstein, Dmitry Balyasny & Mike Rockefeller
00:00:00
ImmuPharma "absolutely delighted" to push on with new clinical trial -Tim McCarthy, FCCA, MBA - Chief Executive Officer, ImmuPharma
00:10:00
David Solomon on Goldman Sachs' Strategic Moves Amid Crisis and Future Outlook | David Solomon, CEO, Goldman Sachs.
00:10:00
Intervention by Massimiliano Bianco, CEO of Iren, at Capri on October 6, 2016.
00:10:00
Mastering Hedge Fund Financials: Insights from AIS Hedge Fund Accounting | Expert Solutions in Fund Administration

© 2017 - Neuhu+